More advanced preparations have also achieved the combined delivery of quercetin and therapeutic nucleic acids, such as the co-delivery of quercetin and shTERT siRNA by RGD-modified mesopore silicon nanoparticles, which can induce apoptosis through the p53/Bax pathway and achieve better tumor suppression effects in ovarian cancer xenograft models [43]. The gene discussed is BAX; the disease is neoplasm.